Skip to content
Full Committee Hearing

Pharmaceutical Patent Issues: Interpreting GATT

Type: Full Committee Hearing
Date:
Time: 10:02am
Location: Dirksen Senate Office Building Room 226

Panel 1

  • Lauch Faircloth

    U.S. Senator from the State of North Carolina
  • John H. Chafee

    U.S. Senator from the State of Rhode Island
  • David Pryor

    U.S. Senator from the State of Arkansas

Panel 2

  • Michael Kantor

    U.S. Trade Representative
    Washington, D.C.
  • William E. Brock

    Chairman Emeritus
    The Brock Group
    Former U.S. Trade Representative

Panel 3

  • Gerald J. Mossinghoff

    Former Commissioner U.S. Patent and Trademark Office
    President
    Pharmaceutical Research and Manufacturers of America
    Washington, D.C.
  • Charles J. Cooper

    Shaw, Pittman, Potts, and Trowbridge
    Washington, D.C.
  • James P. Firman

    Chair, Generic Drug Equality Coalition
    President
    National Council of Aging
    Washington, D.C.
  • Judith Simpson

    President
    United Patients Association for Pulmonary Hypertension, Inc.
    Dekalb, IL
  • Robert J. Gunter

    Chairman, National Pharmaceutical Alliance
    President
    Novo-Pharm USA
    Schaumberg, IL

Panel 4

  • Henry A. Waxman

    Representative in Congress from the State of California

Panel 5

  • John Klein

    Chairman
    Generic Pharmaceutical Industry Association
    Washington, D.C.
  • Bruce Downey

    Chairman, President, and Chief Executive Office
    Barr Laboratories
    Pomona, NY
  • Gerald J. Mossinghoff

    President
    Pharmaceutical Research and Manufacturers Association
    Washington, D.C.
  • David Beier

    Vice President for Government Relations
    Genentech
    San Francisco, CA

Panel 6

  • Henry G. Grabowski

    Professor of Economics
    Duke University
    Durham, NC
  • Daniel Perry

    Executive Director
    Alliance for Aging Research
    Washington, D.C.
  • Dixie Horning

    Executive Director
    Gray Panthers
    Washington, D.C.